Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

QR Code

Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/5a209eb810624fa3b79e6ac0b52cc517
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
par: Maria Vittoria Dieci, et autres
Publié: (2021)

Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
par: Gaia Griguolo, et autres
Publié: (2021)

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
par: Fara Brasó-Maristany, et autres
Publié: (2020)

Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
par: G. Griguolo, et autres
Publié: (2021)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
par: Avisek Majumder, et autres
Publié: (2021)

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.
par: Patrizia Nanni, et autres
Publié: (2013)

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
par: Veronica Giusti, et autres
Publié: (2021)

Remembering Sally Engle Merry: Her scholarship and her legacy
par: Anne Griffiths
Publié: (2021)

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
par: Stenehjem DD, et autres
Publié: (2014)

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
par: Laura Pizzuti, et autres
Publié: (2021)

ZOË BOCCABELLA’S CALABRIAN CHAPTER IN MEZZA ITALIANA AS A SYMBOLIC ELIMINATION OF SOUTHERNESS FROM HER OWN DIASPORIC SELF
par: Teresa Di Somma, et autres
Publié: (2017)

An Islam of Her Own
par: Fatima Seedat
Publié: (2013)

Her majesty the transaction
par: Gaćeša Radmila
Publié: (2021)

In her own time
par: Flora Jung
Publié: (2018)

Her voice lingers on and her memory is strategic: effects of gender on directed forgetting.
par: Hwajin Yang, et autres
Publié: (2013)

May Her Likes Be Multiplied
par: Nancy L. Stockdale
Publié: (2002)

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
par: Advani P, et autres
Publié: (2015)

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
par: Yuefeng Wang, et autres
Publié: (2017)

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer
par: Nindo B. Punturi, et autres
Publié: (2021)

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
par: Yi Ding, et autres
Publié: (2018)

The translator and his/her language/culture
par: Reinhold Utri
Publié: (2021)

Narrative of Her Life: Mary Jemison
Publié: (2017)

Rara and Her Bedtime Story Journey
par: Rudi Suherman
Publié: (2020)

Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
par: Maral Mokhtari, et autres
Publié: (2021)

HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
par: Alison E. Smith, et autres
Publié: (2021)

La escolástica española y la génesis de la filosofía latinoamericana. Alonso Briceño metafísica e individualidad /
par: Cacciatore, Giuseppe
Publié: (2006)

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
par: Yunhua Liu, et autres
Publié: (2018)

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.
par: David Lesniak, et autres
Publié: (2013)

THE EFFECT OF THE DOE WEIGHT ON HER REPRODUCTIVE EFFICIENY
par: Mohammad Ebrahim Ahmed, et autres
Publié: (2021)

REVIEW: Paying with her life for telling it like it is
par: Seumas Phelan
Publié: (2004)

In her own words: Melanesian women in media
par: Faith Valencia-Forrester, et autres
Publié: (2020)

Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
par: Diana B. Peckys, et autres
Publié: (2021)

HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.
par: Merel Gijsen, et autres
Publié: (2010)

Simulation of a flash-flood event over the Adriatic Sea with a high-resolution atmosphere–ocean–wave coupled system
par: Antonio Ricchi, et autres
Publié: (2021)

TROUGH HER EYES. THE ADVENTURES OF MARGARET MCKELVY BIRD
par: Martinic,Mateo
Publié: (2017)

Letter to her Husband, Absent Upon Publick Employment
Publié: (2017)

HER2 breast cancer therapies: a review
par: Conleth G Murphy, et autres
Publié: (2009)

Bevacizumab in the treatment of HER2-negative breast cancer
par: Vito Lorusso
Publié: (2008)

Financial recovery as bankruptcy proceedings or result of her conduct
par: O. YU. Rudakova, et autres
Publié: (2017)

Fundamentos de derecho argentino libro de casos /
par: Genovesi, Luis Mariano
Publié: (2010)